Justice Department, Federal Bureau of Investigation Briefing 2026-06-08

Estimated reading time: 5 minutes

1. FBI Criminal Justice Information Services Division; User Fee Schedule

Link: https://www.federalregister.gov/documents/2026/06/08/2026-11435/fbi-criminal-justice-information-services-division-user-fee-schedule

Sub: Justice Department, Federal Bureau of Investigation

Content: The FBI is authorized to establish and collect fees for providing fingerprint-based and name-based criminal history record information (CHRI) checks submitted by authorized users for noncriminal justice purposes including employment and licensing. A portion of the fee is intended to reimburse the FBI for the cost of providing fingerprint-based and name-based CHRI checks ("cost reimbursement portion" of the fee). The FBI is also authorized to charge an additional amount to defray expenses for the automation of fingerprint identification and criminal justice information services and associated costs ("automation portion" of the fee). This notice provides the revised fee schedule.

2. Agency Information Collection Activities; Proposed eCollection eComments Requested; Revision of a Previously Approved Collection; Juvenile Facility Census Program (JFCP)

Link: https://www.federalregister.gov/documents/2026/06/08/2026-11430/agency-information-collection-activities-proposed-ecollection-ecomments-requested-revision-of-a

Sub: Justice Department

Content: The National Institute of Justice, Office of Justice Programs, Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.

3. Importer of Controlled Substances Application: CalCog Inc.

Link: https://www.federalregister.gov/documents/2026/06/08/2026-11416/importer-of-controlled-substances-application-calcog-inc

Sub: Justice Department, Drug Enforcement Administration

Content: CalCog Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.


Legal Disclaimer

This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.